Observational studyCancer immunology, immunotherapy : CII2026
Site and number of metastases predict outcomes in avelumab maintenance for advanced UC: results from meet-URO 25.
Giandomenico Roviello et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.